Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.
AddressCambridge, Massachusetts, US
Join the #1 platform for brand partnerships
Find the right partners that match your audience
Connect with partners and manage your conversations all in one place
Gain meaningful insights into the success of your partnerships